The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D'Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1880 · Cited by 989
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J., & Fan, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23501 · Cited by 711
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
Kunnumakkara, A. B., Guha, S., Krishnan, S., Diagaradjane, P., Gelovani, J., & Aggarwal, B. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4257 · Cited by 578
Malignant Pleural Mesothelioma
Tsao, A. S., Wistuba, I., Roth, J. A., & Kindler, H. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8523 · Cited by 481
Takeshita, F., Patrawala, L., Osaki, M., Takahashi, R.-U., Yamamoto, Y., Kosaka, N., Kawamata, M., Kelnar, K., Bader, A. G., Brown, D., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.207 · Cited by 420
Bandi, N., Zbinden, S., Gugger, M., Arnold, M., Kocher, V., Hasan, L., Kappeler, A., Brunner, T., & Vassella, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4277 · Cited by 386
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Self-citationMacDiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V. N., Phillips, L., Pattison, S. T., Petti, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1547 · Cited by 272
Self-citationGuled, M., Lahti, L., Lindholm, P. M., Salmenkivi, K., Bagwan, I., Nicholson, A. G., & Knuutila, S. (2009) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20669 · Cited by 259
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Bhattacharya, R., Nicoloso, M., Arvizo, R., Wang, E., Cortez, A., Rossi, S., Calin, G. A., & Mukherjee, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2552 · Cited by 240
miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF
Sun, C.-Y., She, X.-M., Qin, Y., Chu, Z.-B., Chen, L., Ai, L.-S., Zhang, L., & Hu, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs333 · Cited by 221
MicroRNA Signature of Malignant Mesothelioma with Potential Diagnostic and Prognostic Implications
Busacca, S., Germano, S., De Cecco, L., Rinaldi, M., Comoglio, F., Favero, F., Murer, B., Mutti, L., Pierotti, M., & Gaudino, G. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0060oc · Cited by 167
hsa-miR-29c* Is Linked to the Prognosis of Malignant Pleural Mesothelioma
Pass, H. I., Goparaju, C. M. V., Ivanov, S. V., Donington, J. S., Carbone, M., Hoshen, M., Cohen, D., Chajut, A., Rosenwald, S., Dan, H., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3993 · Cited by 161
Kirschner, M. B., Cheng, Y. Y., Badrian, B., Kao, S., Creaney, J., Edelman, J. J., Armstrong, N. J., Vallely, M. P., Musk, A. W., Robinson, B. W. S., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182572e83 · Cited by 136
Self-citationWang, X., Wang, J., Ma, H., Zhang, J., & Zhou, X. (2011) · Medical Oncology · doi:10.1007/s12032-011-9880-5 · Cited by 130
Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma
Ivanov, S. V., Goparaju, C. M. V., Lopez, P., Zavadil, J., Toren-Haritan, G., Rosenwald, S., Hoshen, M., Chajut, A., Cohen, D., & Pass, H. I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100354 · Cited by 129
Kubo, T., Toyooka, S., Tsukuda, K., Sakaguchi, M., Fukazawa, T., Soh, J., Asano, H., Ueno, T., Muraoka, T., Yamamoto, H., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3040 · Cited by 125
Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer
Tanaka, N., Toyooka, S., Soh, J., Kubo, T., Yamamoto, H., Maki, Y., Muraoka, T., Shien, K., Furukawa, M., Ueno, T., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.10.002 · Cited by 113
Gao, S.-M., Yang, J.-J., Chen, C.-Q., Chen, J.-J., Ye, L., Wang, L.-Y., Wu, J.-B., Xing, C., & Yu, K. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-27 · Cited by 99
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
Balatti, V., Maniero, S., Ferracin, M., Veronese, A., Negrini, M., Ferrocci, G., Martini, F., & Tognon, M. G. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820db125 · Cited by 94
Chemotherapy and targeted therapies for unresectable malignant mesothelioma
Kelly, R. J., Sharon, E., & Hassan, R. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.04.014 · Cited by 56
Kurai, J., Chikumi, H., Hashimoto, K., Takata, M., Sako, T., YAMAGUCHI, K., Kinoshita, N., Watanabe, M., Touge, H., Makino, H., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1607 · Cited by 29
Validation of tissue microarray technology in malignant pleural mesothelioma
Kao, S., Lee, K. M. L., Armstrong, N. J., et al. (2011) · Pathology · doi:10.1097/pat.0b013e328342016c · Cited by 29
Cited by
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Emerging concepts of miRNA therapeutics: from cells to clinic
Diener, C., Keller, A., & Meese, E. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 971
van Zandwijk, N., Pavlakis, N., Kao, S. C., Linton, A., Boyer, M. J., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M. J., Bailey, D. L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30621-6 · Cited by 710
Self-citationMicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
Metadata
- Authors
- Reid, G., Pel, M. E., Kirschner, M. B., Cheng, Y. Y., Mugridge, N., Weiss, J., Williams, M., Wright, C., Edelman, J. J. B., Vallely, M. P., McCaughan, B. C., Klebe, S., Brahmbhatt, H., MacDiarmid, J. A., & van Zandwijk, N.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 24
- Issue
- 12
- Pages
- 3128-3135
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2161845665
- Cited by
- 275
- References
- 25
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.